Literature DB >> 31602562

Cost-Effectiveness of Bridging Anticoagulation.

Matthew A Pappas1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31602562      PMCID： PMC7858997          DOI： 10.1007/s11606-019-05322-x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  4 in total

1.  Cost-Effectiveness of Bridging Anticoagulation Among Patients with Nonvalvular Atrial Fibrillation.

Authors:  Matthew A Pappas; Geoffrey D Barnes; Sandeep Vijan
Journal:  J Gen Intern Med       Date:  2019-01-08       Impact factor: 5.128

2.  Personalizing Bridging Anticoagulation in Patients with Nonvalvular Atrial Fibrillation-a Microsimulation Analysis.

Authors:  Matthew A Pappas; Geoffrey D Barnes; Sandeep Vijan
Journal:  J Gen Intern Med       Date:  2017-01-24       Impact factor: 5.128

3.  Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.

Authors:  Maura Marcucci; Gregory Y H Lip; Robby Nieuwlaat; Ron Pisters; Harry J G M Crijns; Alfonso Iorio
Journal:  Am J Med       Date:  2014-05-13       Impact factor: 4.965

4.  Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Authors:  Benjamin A Steinberg; Eric D Peterson; Sunghee Kim; Laine Thomas; Bernard J Gersh; Gregg C Fonarow; Peter R Kowey; Kenneth W Mahaffey; Matthew W Sherwood; Paul Chang; Jonathan P Piccini; Jack Ansell
Journal:  Circulation       Date:  2014-12-12       Impact factor: 29.690
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.